The Big Picture: Dr. Adriana Davis, Family Medicine, “The idea here is to know that drugs like Ozempic and Mounjaro are being used for chronic disease conditions–and you may have to take these medicines indefinitely.”
Doctor’s Expert Insights About Weight Loss and Drugs like Tirzepatide and Ozempic in Georgia
Know this: “So, this study shows significant weight loss with tirzepatide, but highlights a challenge: stopping the drug often leads to weight regain. This isn’t about willpower–it’s about understanding that obesity is a chronic condition that may require ongoing medication. Like many other chronic diseases, obesity needs to be managed. It will require ongoing pharmacotherapy and lifestyle changes. This study serves as a reminder that weight management is a long-term commitment and requires sustained medical and lifestyle interventions. Also, as I’ve been recommending here, make sure that you know your A1C and blood cholesterol levels. Knowing these metrics will be important in guiding how you and your healthcare team treat and manage obesity.” Dr. Puja Uppal, Family Medicine.
Beyond the news: These findings are creating a paradigm shift in how obesity is treated and managed–with an emphasis on long-term pharmacological intervention and lifestyle changes.
Key Findings:
“After 36 weeks of open-label maximum tolerated dose of tirzepatide (10 or 15 mg), adults (n = 670) with obesity or overweight (without diabetes) experienced a mean weight reduction of 20.9%. From randomization (at week 36), those switched to placebo experienced a 14% weight regain and those continuing tirzepatide experienced an additional 5.5% weight reduction during the 52-week double-blind period.” (Study Source)
Health Alert for Rome
Key Drivers in Floyd County:
The study highlighted tirzepatide’s efficacy in maintaining and augmenting initial weight loss…
Read the full article here
